Decline depth
-24.3%
From rolling 252-day high of $643.99, 126d ago.
Past the 20% Watch threshold.
WatchRecovering
TMOThermo Fisher Scientific Inc
Healthcare · Diagnostics & Research · large-cap ($166.4B)
-24.3%
from rolling 252-day high of $643.99 set 2026-01-22 · 126d ago
Current
$487.22
Decline depth
-24.3%
Decline σ
2.7σ
TFC
2/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Since it joined the list
$TMO landed on the list 2026-03-02, down 21.0% from its 52-week high that day — now down -24.3%.
That's 3.9 percentage points deeper than the day it joined. It bottomed 31.9% below that high along the way.
Decline from the 52-week high as it stood on 2026-03-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.
Structural break signals
TMO qualifies for the Watch on decline depth.
Time-frame continuity
2/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
2.7σ
Drop from local high over the last 5 bars, expressed in units of the stock's typical daily volatility (2.23% per day).
The structural read
What price action says about TMO.
TMO qualifies for the Watch on decline depth — down -24.3% from its rolling 252-day high.
Alongside that decline, our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames — moderate or strong time-frame-continuity (TFC) alignment — so the ticker also carries a Recovering badge. The two readings coexist: the tier tells you how deep the damage is, the Recovering badge tells you whether momentum may be turning. Recovering is not a buy signal; it's a structural read.
Broken Stocks stops here — it flags the structure, it doesn't build the upside case. Working out whether TMO's turn is investable is what our sister tool does: ConvictionEdge — triple-engine conviction research on names showing a recovery signal.
Upstream TFC read: strong alignment, current phase daily. Last bar types — daily 2U (green), weekly 2U (green), monthly 2D (green).
Earnings on file: 2026-04-23. Tiering is unaffected by earnings dates — listings reflect price structure only.
52-week range
52W low $385.46
39.4% of range
52W high $643.99
Sector context · Healthcare
194 other Healthcare tickers are on Broken Stocks.
89
Red List
47
Amber
58
Watch
-36.0%
Median decline
Worst in sector: OPRX (-77.1%). Least-bad: MRNA (-20.1%). See all Healthcare listings →
Related — same sector
Closest decliners to TMO
Watch
MCK
McKesson Corporation
Amber List
KOD
Kodiak Sciences Inc
Watch
REGN
Regeneron Pharmaceuticals, Inc.
Amber ListRecovering
RYTM
Rhythm Pharmaceuticals, Inc.
Red ListRecovering
CHE
Chemed Corp
WatchRecovering
GLUE
Monte Rosa Therapeutics, Inc.
Questions about TMO
What people ask.
Why is TMO on Broken Stocks?
TMO qualifies for the Watch on decline depth. It is down -24.3% from its rolling 252-day high of $643.99, set on 2026-01-22 — 126d ago. It additionally carries a Recovering badge — see below.
What does the Recovering badge mean for TMO?
Recovering means our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames (moderate or strong time-frame continuity). It coexists with the decline tier — TMO is still Watch because the rolling-252-day decline hasn't healed, but a bullish setup has formed inside that decline. The two readings answer different questions: the tier tells you how deep the damage is; the Recovering badge tells you whether momentum may be turning. It's not a buy recommendation.
Is TMO a falling knife?
No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. TMO is down -24.3% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.
Is TMO a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is TMO trading inside its 52-week range?
At $487.22, TMO sits 39.4% of the way from its 52-week low ($385.46) to its 52-week high ($643.99). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has TMO been declining?
The current 24.3% decline accrued over 126d, which annualizes to roughly -70.4% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does TMO compare to its sector?
There are 194 other Healthcare tickers on Broken Stocks: 89 Red, 47 Amber, 58 Watch, with 107 showing recovering structural signals. Median sector decline is -36.0% — TMO's decline is shallower than the sector median.
Does TMO's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-04-23) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.